Pfizer is paying $1.25 billion to join the PD-(L1)xVEGF bispecific race. | Pfizer is paying $1.25 billion to join the ...

The FDA has cleared the first blood test to diagnose Alzheimer's which works by measuring the amount of pTau 217 and ...

A highly sensitive real-time PCR-based systems helps scientists rapidly detect microbial contamination in cell therapy ...

New tools for computer-aided retrosynthesis help scientists streamline route planning, reducing the financial and environmental costs of drug development.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...